NCT02711098 - IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial. | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 14, 2018

Study Completion Date

January 14, 2018

Conditions

Cardiac Arrest

Interventions

BIOLOGICAL

"Inflammatory biomarkers dosage Hypothermia Arm"

There is 6 dosage of inflammatory biomarker per patient included: H0, H12, H24, H36, H48 and H72 during targeted temperature management between 33°C and 37°C.

BIOLOGICAL

"Inflammatory biomarkers dosage Normothermia Arm"

There is 6 dosage of inflammatory biomarker per patient included: H0, H12, H24, H36, H48 and H72 during targeted temperature management at 37°C.

Trial Locations (14)

21079

CHU Dijon, Dijon

74374

Centre hospitalier d'Annecy, Annecy

Unknown

Medical Intensive Care Unit, Clermond Ferrand

Medical Surgical Intensive Care Unit, La Roche-sur-Yon

Medical Surgical Intensive Care Unit, Lens

Medical Surgical Intensive Care Unit, Limoges

Medical Surgical Intensive Care Unit, Montauban

Medical Intensive Care Unit, Nantes

CHU Orleans, Orléans

Medical Intensive Care Unit, Poitiers

Medical Surgical Intensive Care Unit, Rodez

Medical Surgical Intensive Care Unit, Saint-Brieuc

Medical Surgical Intensive Care Unit, St-Malo

CHU Tours, Tours

All Listed Sponsors

lead

Centre Hospitalier Departemental Vendee

OTHER